# Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI

Study · id `cardio:ct-nct06353594` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06353594](<https://clinicaltrials.gov/study/NCT06353594>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06353594

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1272 participants.

## Technical summary

Registry record NCT06353594. Randomized; no masking; primary purpose treatment. Start 2024-03-11 (actual); primary completion 2026-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1272 participants (planned count; ClinicalTrials.gov record NCT06353594, source copy `cardio:ctgov-nct06353594-2026-05-28`, retrieved 2026-10-26)
- Started: 2024-03-11 (actual) (ClinicalTrials.gov record NCT06353594, source copy `cardio:ctgov-nct06353594-2026-05-28`, retrieved 2026-10-26)
- Primary completion: 2026-09 (anticipated) (ClinicalTrials.gov record NCT06353594, source copy `cardio:ctgov-nct06353594-2026-05-28`, retrieved 2026-10-26)
- Completion: 2035-09 (anticipated) (ClinicalTrials.gov record NCT06353594, source copy `cardio:ctgov-nct06353594-2026-05-28`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT06353594, source copy `cardio:ctgov-nct06353594-2026-05-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06353594-2026-05-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI
- Acronym: COPERNICAN
- Condition: ST Elevation Myocardial Infarction
- Intervention (Device): Primary PCI
- Lead sponsor: Hospital Universitario La Fe
- Lead sponsor class: OTHER
- Collaborator: ERA4Health
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Hospital Universitario La Fe (`cardio:org-hospital-universitario-la-fe`)

## Provenance

Content hash: c0dc0caec705bc3ea959eefbc6d8d93f38e47a7e4bf1a1ecdbcc865219e564ce
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
